Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 06/02/2026 GMT			5-day change	1st Jan Change
295.50 ^DKK	+5.29%		-20.04%	-9.15%

02-07	Hims to stop offering GLP-1 pill after FDA warned of crackdown	RE
02-07	How far are these giants from their peak?

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	1,674,992	2,118,803	3,112,331	2,772,285	1,445,242	1,313,091	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-9.14%	-	-
Enterprise Value (EV) ¹	1,684,152	2,121,013	3,109,107	2,848,764	1,445,242	1,409,653	1,395,576	1,376,189
Change	-	25.94%	46.59%	-8.37%	-49.27%	-2.46%	-1%	-1.39%
P/E ratio	35.4x	38.4x	37.5x	27.6x	14.1x	14x	13.2x	12x
PBR	24x	25.6x	29.4x	19.3x	-	6.02x	5.3x	4.64x
PEG	-	2.2x	0.7x	1.3x	7.98x	-1.74x	2.46x	1.2x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	4.49x	4.25x	4.02x
EV / Revenue	12x	12x	13.4x	9.81x	4.68x	4.82x	4.52x	4.21x
EV / EBITDA	26x	25.8x	27.8x	19.3x	9.66x	10.2x	9.53x	8.84x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	11.3x	11.9x	11.1x	10.3x
EV / FCF	57.4x	37x	45.5x	38.6x	-	23.8x	17.5x	15.2x
FCF Yield	1.74%	2.7%	2.2%	2.59%	-	4.19%	5.72%	6.6%
Dividend per Share ²	5.2	6.2	9.4	11.4	-	10.77	11.53	12.99
Rate of return	1.41%	1.32%	1.35%	1.83%	-	3.65%	3.9%	4.4%
EPS ²	10.37	12.22	18.62	22.63	23.03	21.17	22.31	24.62
Distribution rate	50.1%	50.7%	50.5%	50.4%	-	50.9%	51.7%	52.8%
Net sales ¹	140,800	176,954	232,261	290,403	309,064	292,375	309,065	326,786
EBITDA ¹	64,669	82,171	111,987	147,446	149,640	137,714	146,372	155,740
EBIT ¹	58,644	74,809	102,574	128,339	127,658	118,753	125,976	133,110
Net income ¹	47,757	55,525	83,683	100,988	102,434	93,968	98,073	104,954
Net Debt ¹	9,160	2,210	-3,224	76,479	-	96,562	82,485	63,098
Reference price ²	367.50	469.00	698.10	624.20	325.25	295.50	295.50	295.50
Nbr of stocks (in thousands)	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	4,443,625	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	05/02/25	03/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	13.96x	4.82x	10.24x	3.65%	208B
ELI LILLY AND COMPANY	46.93x	15.27x	33.84x	0.55%	947B
JOHNSON & JOHNSON	23.2x	6.43x	17.86x	2.15%	578B
ABBVIE INC.	62.39x	7.4x	18.34x	2.93%	395B
ROCHE HOLDING AG	18.44x	4.63x	11.48x	2.82%	367B
MERCK & CO., INC.	15.75x	5.05x	11.01x	2.65%	303B
ASTRAZENECA PLC	30.26x	5.44x	16.24x	1.69%	298B
NOVARTIS AG	20.34x	5.75x	14.03x	2.97%	295B
AMGEN INC.	29.86x	6.92x	11.85x	2.49%	207B
GILEAD SCIENCES, INC.	22.37x	6.92x	12.65x	2.18%	189B
Average	28.35x	6.86x	15.75x	2.41%	378.65B
Weighted average by Cap.	32.32x	8.29x	19.31x	2.07%